Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PTH > liver 2 > Flashcards

liver 2 Flashcards

1
Q

What is the definition of acute hepatitis?

A

Infection for less than 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the definition of chronic hepatitis?

A

Infection for more than 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the incubation period for Hepatitis A Virus (HAV)?

A

14–50 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some general symptoms of HAV infection?

A
  • Nausea
  • Vomiting
  • Diarrhea
  • Myalgia
  • Fever
  • Abdominal pain
  • Jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is Hepatitis A primarily transmitted?

A

Through the fecal–oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mortality rate associated with HAV?

A

Less than 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the main management approach for acute HAV infection?

A

Supportive care; avoid hepatotoxic medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What antibody indicates recent HAV infection?

A

IgM antibody to HAV (anti-HAV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What populations require preexposure prophylaxis with HAV vaccine?

A
  • All children older than 1 year
  • People experiencing homelessness
  • International travelers
  • Men who have sex with men
  • Injection or non-injection drug users
  • People with occupational risk of exposure
  • Patients with chronic liver disease or HIV infection
  • Pregnant women at risk
  • Individuals with close contact with international adoptees
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the postexposure prophylaxis recommendation for unvaccinated individuals after HAV exposure?

A

Administer HAV vaccine or immune globulin within 2 weeks of exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main mode of transmission for Hepatitis B Virus (HBV)?

A
  • Parenteral
  • Bodily fluids
  • Sexual contact
  • Perinatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the risk of developing chronic HBV infection after an acute infection in adults?

A

2%–6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the serologic markers for HBV infection?

A
  • HBsAg
  • HBcAg
  • HBeAg
  • Anti-HBs
  • Anti-HBc IgM
  • Anti-HBc IgG
  • Anti-HBe
  • HBV DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the first detectable serum antigen during acute HBV infection?

A

HBsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does the presence of Anti-HBs indicate?

A

Protective immunity against HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the treatment recommendations for patients with chronic HBV infection?

A
  • Monitor for spontaneous conversion
  • Consider antiviral treatment if ALT is elevated and HBV DNA is high
  • Treat patients meeting chronic infection criteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Name two preferred antiviral medications for HBV treatment.

A
  • Tenofovir
  • Entecavir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the significance of HBeAg-positive disease in HBV?

A

Indicates ongoing active viral replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a major side effect associated with reverse transcriptase inhibitors?

A

Lactic acidosis and severe hepatomegaly with steatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the preferred antiviral therapies for HBV in patients with decompensated cirrhosis?

A
  • Tenofovir disoproxil fumarate
  • Tenofovir alafenamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the dosing recommendation for Entecavir in treatment-naive patients?

A

0.5 mg orally once daily for patients older than 16 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the recommended monitoring for patients on Tenofovir?

A

Periodic monitoring of renal function and liver function tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the association of Tenofovir alafenamide in terms of renal and bone toxicity?

A

Associated with less renal and bone toxicity

This is significant in managing patients with chronic HBV infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the best predictors of response to Pegylated interferon treatment?

A
  • High pretreatment ALT
  • Low serum HBV DNA
  • Presence of active inflammation on biopsy
  • Acquisition of infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What serious adverse effects are associated with interferon treatment?
* Bone marrow suppression * Leukopenia * Thrombocytopenia * Depression * Pulmonary hypertension
26
What is the recommended dosing for Pegasys (pegylated-α-2a)?
180 mcg subcutaneously once weekly for 48 weeks
27
What are the treatment options for HBeAg positive HBV?
* Entecavir * Tenofovir
28
What are the adverse effects of oral agents for HBV?
* Predisposition to infections * CNS effects (depression, psychosis, anxiety) * Flulike symptoms * Anorexia, alopecia, thyroid dysfunction
29
What is the duration of treatment with PEG-IFNα for HBeAg negative HBV?
≥ 1 year
30
What are the vaccination schedules for Hepatitis B vaccines for individuals aged 18 and older?
* Heplisav-B: Two doses (0 and 1 month) * PreHevbrio: Three doses (0, 1, and 6 months) * Twinrix: Three doses (0, 1, and 6 months)
31
What is the postexposure prophylaxis for children born to HBsAg-positive mothers?
First dose of vaccine plus HBV immune globulin within 12 hours of birth
32
What are the main risk factors for Hepatitis C Virus (HCV) infection?
* HIV infection * Current or former injection drug use * Maintenance hemodialysis * Prior transfusions or organ transplants
33
What is defined as chronic Hepatitis C infection?
Presence of viral RNA in the serum for 6 months or more
34
What are the clinical signs and symptoms of Hepatitis C infection?
* Nausea * Abdominal pain * Jaundice * Fever * Malaise
35
What is the significance of sustained virologic response (SVR) in Hepatitis C treatment?
SVR is the absence of detectable HCV RNA 12 weeks after treatment, considered a virologic cure
36
What are the adverse effects associated with Ribavirin treatment?
* Hemolytic anemia * Teratogenicity * Pancreatitis * Pulmonary dysfunction
37
What is the weight-based dosing of Ribavirin for patients weighing 75 kg or less?
1000 mg daily
38
What are the testing recommendations for HCV?
* One-time testing for all individuals aged 18 and older * Pregnant women with each pregnancy * Individuals with HCV risk factors
39
What is the primary method for initial screening of HCV?
Serum anti-HCV antibodies
40
What is the recommended monitoring for patients receiving DAA therapy?
Monitor for HBV reactivation
41
What is the recommended action if hemoglobin drops more than 2 g/dL during treatment?
Decrease the dose to 600 mg/day.
42
What should be done if hemoglobin drops to less than 12 g/dL after dose reduction?
Discontinue treatment.
43
What medications can be used to stimulate red blood cell production?
Epoetin or darbepoetin.
44
Which HCV genotypes does sofosbuvir treat?
HCV genotypes 1–6.
45
What is the dosing for sofosbuvir?
400 mg tablet once daily with or without food.
46
What are the adverse effects of sofosbuvir?
Fatigue, headache.
47
Which drug interactions should be avoided with sofosbuvir?
* Potent P-glycoprotein inducers * Amiodarone * Acid-suppressive therapy
48
What is the indication for the combination of velpatasvir and sofosbuvir?
Genotype 1–6 infection.
49
What is the dosing for velpatasvir/sofosbuvir?
Velpatasvir 100 mg / sofosbuvir 400 mg fixed-dose combination tablet once daily for 12 weeks.
50
What are the adverse effects of the combination velpatasvir/sofosbuvir?
Headache and fatigue.
51
What is the indication for glecaprevir/pibrentasvir (Mavyret)?
Genotype 1–6 infection with or without compensated cirrhosis.
52
What is the dosing for glecaprevir/pibrentasvir?
Three tablets once daily with food.
53
What are the adverse effects associated with glecaprevir/pibrentasvir?
Headache, fatigue, nausea.
54
What should be monitored when using Grazoprevir and Elbasvir?
ALT elevations and testing for NS5A resistance-associated substitutions.
55
What is the indication for the combination of velpatasvir, sofosbuvir, and voxilaprevir?
Genotypes 1–6 infection in treatment-experienced patients.
56
What are the adverse effects of velpatasvir, sofosbuvir, and voxilaprevir?
Headache, fatigue, diarrhea, nausea.
57
What is the recommended treatment for treatment-naive patients without cirrhosis?
Glecaprevir/pibrentasvir daily with food for 8 weeks.
58
What tests are performed at baseline for HCV monitoring?
* HCV RNA * Genotype * Quantitative HCV RNA * CBC * Liver function tests * Calculated GFR
59
What should be checked after HCV treatment to assess for SVR?
HCV RNA at 12 weeks.
60
True or False: There is a vaccine available for HCV.
False.
61
What modifications can reduce the risk of HCV transmission?
* Intravenous drug abuse prevention * Appropriate barrier contraception * Avoid blood exposure
62
Fill in the blank: Sofosbuvir should not be coadministered with _______ due to symptomatic bradycardia.
Amiodarone

PTH (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions